Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by Lookingforclueson Oct 03, 2021 7:38pm
219 Views
Post# 33959297

Mugs

Mugs

There are a few who think you are pumping this Equity! 
Reasonable positive comments are good, but continually refusing to accept that this equity was approx $4+, going to $10 and now surviving at a bit over $5 due to Buy Backs is 'beyond the pale'!
 

With the current finances and looking back, this Equity is presently not worth the present approx $5.
You didn't say that you were not connected to Mgm't, so it leaves a bit of a bad taste in investor's mouths, with you 'salivating' over it 20 times per day on 2 boards!
Please take a 'look into yourself' and size up what ails you.

There is something wrong here!  Samira owns 60,000 shares...only, and some people are buying 300/600.  Not a great advert for your description......It is a real shame.
 Ty 

 

<< Previous
Bullboard Posts
Next >>